Scleroderma Risk Model for 5 Year Survival

Purpose: To predict survival in a patient presenting with scleroderma using the simple risk model of Bryan et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient presenting with scleroderma?

Yes

ESR at initial presentation

mm per hour

Percent carbon monoxide diffusing capacity at initial presentation (enter from 0 to 100)

percent

Urine protein at presentation

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Total score

Predicted risk of 5-year mortality

Predicted survival at 5-years

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Clinical Diagnosis, Including Family History For Genetics
- ARA Scleroderma Criteria Cooperative Study Preliminary Clinical Criteria for Systemic Sclerosis
Imaging Studies
Laboratory Tests
Other Testing
Criteria For Diagnosis
Severity, Prognosis, Stage
Differential Diagnosis And Mimics, Red Flags

Therapy

Physical And Lifestyle
- Drug Induced Scleroderma

Monitoring

Response To Therapy
Disease Progression
Comorbid Conditions
- Prognostic Factors for Patient with Juvenile Systemic Sclerosis
- Lung Severity Scale of Medsger for Patient with Systemic Sclerosis

Specialty

Immunology/Rheumatology

Objective

risk factors
severity
prognosis
stage
disease progression
end-of-life
palliative care

ICD-10

M34 - Systemic sclerosis

Info

Purpose: To predict survival in a patient presenting with scleroderma using the simple risk model of Bryan et al.

Specialty: Immunology/Rheumatology

Objective: risk factors, severity, prognosis, stage, disease progression, end-of-life, palliative care

ICD-10: M34,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path